2023
Entrant Company
Category
Client's Name
Country / Region
Unlocking the Proteome -The NULISA™ Platform sets a new standard in proteomic analysis with attomolar sensitivity, allowing for unprecedented biomarker detection and quantitation.
By leveraging a proprietary sequential immunocomplex capture and release mechanism and the latest advances in Next Generation Sequencing (NGS), the NULISA technology provides both ultra-high sensitivity and scalable multiplexing.
Credits
Entrant Company
Maravai LifeSciences & TriLink BioTechnologies
Category
Website - Biotechnology
Country / Region
United States
Entrant Company
Freelance
Category
Marketing & Promotional - Illustration
Country / Region
United States
Entrant Company
Miami Ad School New York
Category
Student Submission - Student AD
Country / Region
United States
Entrant Company
VLab
Category
Experiential & Immersive - Multi-Channel Experience (NEW)
Country / Region
United States